Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis

Exclusion Criteria

• •Presence of endogenous anterior uveitis diagnosed for \> 2 weeks prior to enrollment in the study.
• •Presence of intermediate uveitis, posterior uveitis or panuveitis in either eye.
• •Instillation of any topical corticosteroid or NSAID in the study eye within 7 days of instillation of study drug.
• •History of glaucoma or clinically significant ocular hypertension in the opinion of the Investigator involving an IOP ≥ 21 millimeters mercury in either eye.
• •History of steroid-induced elevation of intraocular pressure.
• •Any confirmed or suspected active viral, bacterial or fungal keratoconjunctival disease in either eye.
• •History of glaucoma or clinically significant ocular hypertension in the opinion of the Investigator involving an intraocular pressure (IOP) \> 21 mmHg in either eye.
• •Corneal abrasion or ulceration in either eye.
• •Pregnancy or lactation.